DNA, Ginkgo's Class B and Ginkgo's Common stock, compared from Ginkgo's SEC filings. Each fact links the filing it comes from.
DNA, Class B and Common stock shares have the same economic rights, share for share.
“Shares of Class A Common Stock, shares of Class B Common Stock and shares of Class C Common Stock shall be treated equally, identically and ratably, on a per share basis, with respect to any Distribution paid or made by the Corporation (including with respect to the form, amount and timing thereof), unless different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock, by the affirmative vote of the holders of a majority of the outstanding shares of Class B Common Stock and by the affirmative vote of the holders of a majority of the outstanding shares of Class C Common Stock, each voting separately as a class; provided, however, that, in the event that a Distribution is paid in the form of Common Stock (or Rights to acquire such stock), holders of Class A Common Stock shall receive Class A Common Stock (or Rights to acquire such stock, as the case may be), holders of Class B Common Stock shall receive Class B Common Stock (or Rights to acquire such stock, as the case may be) and hol”
Each DNA share has one vote. Each Class B share has 10 votes.
The class record does not settle Common stock's votes per share.
On converting Class B, the filing says:
“Future transfers of shares of Class B common stock to persons other than Ginkgo directors and employees, or trusts or legal entities through which the right to vote the shares of Class B common stock held thereby is exercised exclusively by one or more of Ginkgo’s directors or employees (any such director, employee, trust or legal entity, an “Eligible Holder”), or the holder of shares of Class B common stock ceasing to be an Eligible Holder, will generally result in those shares converting to shares of Class A common stock on a one-to-one basis, subject to certain exceptions and unless a majority of the independent directors of our board of directors determine that such transfer or event will not result in such automatic conversion.”
The class record does not settle whether DNA and Common stock can be converted.
On October 30, 2026 there were 53,943,682 DNA shares, 7,881,331 Class B shares and 3,000,000 Common stock shares outstanding.
Source: Cover of dna-20260930.htm, filed November 9, 2026 · 0001628280-26-072290
Share of the economics: DNA about 83%, Class B about 12%, Common stock about 5%.
Calculated from the shares outstanding above and each class's economic rights per share (DNA 1, Class B 1, Common stock 1)
Votes per share are not settled for every class, so the share of the votes is not calculated.
Not answered yet. The class record has no holders. This needs the beneficial ownership table from Ginkgo's proxy statement, cited, before it can be answered.
Every sentence is built from the reviewed class record, not written by hand; a new filing updates it.
Loading...